The CSP1 subtype gained a higher microsatellite instability (MSI) score, whereas the CPCS2 subtype obtained a higher cancer-associated fibroblast (CAF) score, stemness-associated score, dysfunction score and tumor immune dysfunction and rejection score (TIDE) (Fig. 6F). This evidence concerns the gene CSP1 and neoplasm.